Camelot Portfolios, LLC Agenus Inc Transaction History

Camelot Portfolios, LLC

  • $96.8 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024
BUY
$0.63 - $1.14 $8,883 - $16,073
14,100 New
14,100 $11,000
Q1 2023

Apr 20, 2023
BUY
$1.45 - $2.95 $5,945 - $12,095
4,100 Added 41.0%
14,100 $21,000
Q4 2022

Jan 25, 2023
BUY
$2.02 - $3.25 $20,200 - $32,500
10,000 New
10,000 $0

Others Institutions Holding AGEN

# of Institutions
8
Shares Held
2M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Camelot Portfolios, LLC Portfolio

Follow Camelot Portfolios, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camelot Portfolios, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email